156 related articles for article (PubMed ID: 22273699)
1. Gene expression changes associated with the progression of intraductal papillary mucinous neoplasms.
Jury RP; Thibodeau BJ; Fortier LE; Geddes TJ; Ahmed S; Pruetz BL; Farinola MA; Wilson GD
Pancreas; 2012 May; 41(4):611-8. PubMed ID: 22273699
[TBL] [Abstract][Full Text] [Related]
2. Intraductal papillary mucinous neoplasm.
Shi C; Hruban RH
Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
[TBL] [Abstract][Full Text] [Related]
3. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas.
Corcos O; Couvelard A; Dargère D; Sauvanet A; Hammel P; Paradis V; Lévy P; Ruszniewski P; Bedossa P
Pancreas; 2012 Mar; 41(2):169-74. PubMed ID: 22076567
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T
Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
[TBL] [Abstract][Full Text] [Related]
6. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
Lubezky N; Loewenstein S; Ben-Haim M; Brazowski E; Marmor S; Pasmanik-Chor M; Oron-Karni V; Rechavi G; Klausner JM; Lahat G
Surgery; 2013 May; 153(5):663-72. PubMed ID: 23305591
[TBL] [Abstract][Full Text] [Related]
8. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
9. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas.
Sato N; Goggins M
J Hepatobiliary Pancreat Surg; 2006; 13(4):280-5. PubMed ID: 16858538
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
[TBL] [Abstract][Full Text] [Related]
12. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
[TBL] [Abstract][Full Text] [Related]
13. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
[TBL] [Abstract][Full Text] [Related]
14. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
15. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
Wada K
J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
[TBL] [Abstract][Full Text] [Related]
16. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
[TBL] [Abstract][Full Text] [Related]
17. Familial intraductal papillary mucinous neoplasms of the pancreas.
Rebours V; Couvelard A; Peyroux JL; Sauvanet A; Hammel P; Ruszniewski P; Lévy P
Dig Liver Dis; 2012 May; 44(5):442-6. PubMed ID: 21824831
[TBL] [Abstract][Full Text] [Related]
18. Does a family history of pancreatic ductal adenocarcinoma and cyst size influence the follow-up strategy for intraductal papillary mucinous neoplasms of the pancreas?
Mandai K; Uno K; Yasuda K
Pancreas; 2014 Aug; 43(6):917-21. PubMed ID: 24743378
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.
Sato N; Fukushima N; Maitra A; Iacobuzio-Donahue CA; van Heek NT; Cameron JL; Yeo CJ; Hruban RH; Goggins M
Am J Pathol; 2004 Mar; 164(3):903-14. PubMed ID: 14982844
[TBL] [Abstract][Full Text] [Related]
20. Locus/chromosome aberrations in intraductal papillary mucinous neoplasms analyzed by fluorescence in situ hybridization.
Miyabe K; Hori Y; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Kato A; Ohara H; Joh T; Inagaki H
Am J Surg Pathol; 2015 Apr; 39(4):512-20. PubMed ID: 25517961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]